Filtered By:
Specialty: Pharmaceuticals
Education: Study
This page shows you your search results in order of date.
Order by Relevance | Date
Total 838 results found since Jan 2013.
Covid Drug Paxlovid Now Less Effective Than In Early Trials —But It’s Still Great At Preventing Death
The study found Paxlovid is now less effective at keeping patients out of the hospital, but still remains highly effective at stopping death.
Source: Forbes.com Healthcare News - September 21, 2023 Category: Pharmaceuticals Authors: William Skipworth, Forbes Staff Tags: Business /business Innovation /innovation Healthcare /healthcare Breaking breaking-news Coronavirus topline Source Type: news
Infection With Omicron Less Likely to Result in Post-COVID-19 Condition
MONDAY, Sept. 18, 2023 -- The risk for post-COVID-19 condition (PCC) is reduced in association with infection with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) omicron variant, according to a study published online Aug. 25 in the...
Source: Drugs.com - Pharma News - September 18, 2023 Category: Pharmaceuticals Source Type: news
SARS-CoV-2 Omicron Infection Linked to Increased Risk of Reinfection
THURSDAY, Aug. 24, 2023 -- Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) omicron infection is associated with increased risk of reinfection among residents of long-term care and retirement homes, according to a study published online...
Source: Drugs.com - Pharma News - August 24, 2023 Category: Pharmaceuticals Source Type: news
Long COVID May Affect More Patients Than Previously Thought
WEDNESDAY, Aug. 23, 2023 -- Some patients with postviral syndrome (PVS) after suspected COVID-19 have detectable severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-specific humoral and cell-mediated immune responses, according to a study...
Source: Drugs.com - Pharma News - August 23, 2023 Category: Pharmaceuticals Source Type: news
Study: 85% Of Healthcare Workers Nose-Pick, More Than Triples Covid-19 Risk
Those who admitted picking their noses were 3.8 times as likely to catch the severe acute coronavirus 2 (SARS-CoV-2) as those who claimed that they didn't.
Source: Forbes.com Healthcare News - August 5, 2023 Category: Pharmaceuticals Authors: Bruce Y. Lee, Senior Contributor Tags: Healthcare /healthcare Innovation /innovation business pharma standard Source Type: news
Study: Nose Picking Associated With 280% Higher Covid-19 Risk
Those who admitted picking their noses were 3.8 times as likely to catch the severe acute coronavirus 2 (SARS-CoV-2) as those who claimed that they didn't.
Source: Forbes.com Healthcare News - August 5, 2023 Category: Pharmaceuticals Authors: Bruce Y. Lee, Senior Contributor Tags: Healthcare /healthcare Innovation /innovation business pharma standard Source Type: news
InnovationRx: Lilly ’s Alzheimer’s Drug Candidate Slows Cognitive Decline, Study Suggests
InnovationRx is your weekly digest of healthcare news. Sign up!
Source: Forbes.com Healthcare News - July 20, 2023 Category: Pharmaceuticals Authors: Alex Knapp, Forbes Staff Tags: Science /science Innovation /innovation Healthcare /healthcare Venture Capital /venture-capital Editors' Pick editors-pick Newsletter No Paywall no-paywall Coronavirus technology alexknappblog premium Source Type: news
Twelve Symptoms Contribute to Postacute Sequelae of SARS-CoV-2
FRIDAY, June 2, 2023 -- A group of symptoms has been identified that can define postacute sequelae of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection (PASC), according to a study published online May 25 in the Journal of the...
Source: Drugs.com - Pharma News - June 2, 2023 Category: Pharmaceuticals Source Type: news
Preexisting OSA Linked to Odds of Postacute Sequelae of SARS-CoV-2
THURSDAY, May 18, 2023 -- Preexisting obstructive sleep apnea (OSA) is associated with increased odds of probable postacute sequelae of severe acute respiratory syndrome coronavirus 2 (PASC), according to a study published online May 11 in...
Source: Drugs.com - Pharma News - May 18, 2023 Category: Pharmaceuticals Source Type: news
SARS-CoV-2 Infection Linked to Increased Risk for Diabetes
TUESDAY, April 18, 2023 -- Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is associated with an increased risk for diabetes, according to a study published online April 18 in JAMA Network Open.
Zaeema Naveed, M.B.B.S., Ph.D.,...
Source: Drugs.com - Pharma News - April 18, 2023 Category: Pharmaceuticals Source Type: news
Ursodeoxycholic Acid Cuts SARS-CoV-2 Infection, Severity
MONDAY, April 10, 2023 -- Ursodeoxycholic acid (UDCA) is associated with a reduction in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and COVID-19 severity in patients with cirrhosis, according to a study published online...
Source: Drugs.com - Pharma News - April 10, 2023 Category: Pharmaceuticals Source Type: news
You Can Get Covid-19 From Coronavirus-Contaminated Surfaces, New Study Confirms
A study published The Lancet Microbe provides further support for regularly cleaning and disinfecting high-touch surfaces.
Source: Forbes.com Healthcare News - April 8, 2023 Category: Pharmaceuticals Authors: Bruce Y. Lee, Senior Contributor Tags: Healthcare /healthcare Innovation /innovation Science /science business pharma standard Source Type: news
Risk for GI Disorders Increased After Acute Phase of COVID-19
MONDAY, March 27, 2023 -- People with severe acute respiratory syndrome coronavirus 2 infection have an increased risk for gastrointestinal disorders after the acute phase of COVID-19, according to a study published online March 7 in Nature...
Source: Drugs.com - Pharma News - March 27, 2023 Category: Pharmaceuticals Source Type: news
A nasal spray protects against coronavirus infection - Effective also against recent immune-evasive variants
Researchers have developed a molecule that is, when administered nasally, extremely effective in preventing the disease caused by all known variants of the SARS-CoV-2 virus. The molecule can be a key tool in preparing for future pandemics, as it is aimed at preventing both the transmission and spread of the virus.
In laboratory animal studies, a molecule known as TriSb92, developed by researchers at the University of Helsinki, has been confirmed as affording effective protection against coronavirus infection.
Source: World Pharma News - March 24, 2023 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news
Impact of COVID-19 pandemic on the availability of maternal and child health products and childhood vaccines
ConclusionThis study illustrates that the availability of key essential medicines for maternal and child health in the study area was low. The overall stock-out situation of MCH products has worsened during COVID-19 compared to pre-COVID-19 pandemic. None of the surveyed MCH products met the ideal availability benchmark of 80% in the public hospitals. To allow governments to guarantee these products are constantly available and affordable, a variety of policy frameworks and choices addressing inevitable epidemics should exist.
Source: Journal of Pharmaceutical Policy and Practice - March 2, 2023 Category: Pharmaceuticals Source Type: research
